영동일고 고1 2025 1학기 기말고사 영어 내신 분석

A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity. DNA testing and analysis company Nucleus Genomics has announced the world's first genetic (A) software that helps parents pursuing IVF see and understand the complete genetic profile of each of their embryos. By choosing embryos best suited to parents' hopes, having the lowest disease risk profiles, parents can theoretically boost their children's chances of living longer and healthier lives. It tests for markers for common conditions like diabetes, coronary artery disease, and high blood pressure, and genetic contributions to various cancers. It also covers mental health risks, such as depression and anxiety disorders, as well as physical traits like eye color, hair color, height, BMI, and even IQ-related markers. The test offers a (B) genetic profile, allowing prospective parents to compare multiple embryos on these diverse and overall attributes before choosing one for implantation. But the practice also raises (C) concerns about choosing embryos based on probabilities. Emma Waters, a policy analyst at The Heritage Foundation, responded to tweets about the project. "I only wanted you because you were a girl and the right kind of healthy. I destroyed the other 19 human embryos that your father and I created. Don't worry, it's not eugenics, it's only science." She also said, "The selection of a living human being based on certain traits or conditions,-i.e., choosing which embryos live and which ones are destroyed based on factors like health, sex, and IQ-poses a significant moral problem." 10 (A) o (B) c (C) e